Loading quotes...

Forecast

The analysts' average price target is €1.79 (+14.01%). The median is €1.79 (+14.01%).

Buy	6
Hold	11
Sell	4

News Go to news feed

Clarivate reports Q2 revenue decline and confirms full-year guidance

Clarivate reported a 5.5% decline in Q2 revenue to $587.3 million, missing analysts’ estimates, while adjusted earnings per share of $0.19 were slightly above expectations. The company recorded a net loss of $268.6 million; adjusted net income was $123.1 million and adjusted EBITDA was $247.2 million, below consensus. Clarivate attributed the revenue decline to inorganic divestitures, lower transaction-based revenues and shifts to subscriptions; organic subscription revenue rose 0.7%. The company confirmed full-year guidance of $2.3–2.42 billion in revenue, adjusted diluted EPS of $0.70–0.80 and free cash flow of $365–435 million, and pointed to the announced sale of its Life Sciences & Healthcare unit. » More on de.investing.com
Clarivate appoints Michael Easton as CFO effective August 8, 2026

Clarivate has named Michael Easton executive vice president and chief financial officer, effective August 8, 2026. He succeeds Jonathan Collins, who is leaving the company, and brings more than 25 years of experience in finance, accounting and operations. Easton previously served as senior vice president and chief accounting officer at Clarivate, overseeing controllership, financial reporting, treasury, and financial planning and analysis. Clarivate also released separate financial results for the second quarter of 2026 today. » More on de.investing.com
Clarivate to sell life sciences and healthcare business to Altaris for $600 million

Clarivate signed a definitive agreement to sell its Life Sciences & Healthcare segment to Altaris for about $600 million. The deal comprises $500 million cash, a $75 million seller note and $25 million deferred cash tied to transition services. Clarivate plans to use proceeds to reduce debt and to focus on becoming a subscription-first provider of technology-enabled services and workflow software. » More on finance.yahoo.com

Financials

In the last quarter, Clarivate had revenue of €514.6m and net profit of -€235.35m

(EUR)	June 2026	YoY
Revenue	514.6m	2.39%
Gross profit	352.06m	0.68%
Net profit	-235.35m	285.27%
EBITDA	-12.71m	106.04%

Fundamentals

Metric	Value
Market capitalization	€1.07bn
Number of shares	639.66m
52-week high/low	€3.47 - €1.27
Dividends	No
Beta	1.40
P/E ratio	-3.59
PEG ratio	0.02
P/B ratio	0.26
P/S ratio	0.50

Company profile

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

Name	Clarivate
CEO	Matitiahu Shem Tov
Headquarters	London, gl United Kingdom
Website	clarivate.com
Sector	Industrials
Industry	Professional Services
IPO	29/10/2018
Employees	12,000